Medibio Limited is an evidence-based medical technology company that is developing the world’s first objective diagnostic system for mental health illnesses. Medibio Limited is listed on the Australian Stock Exchange (ASX: MEB) and also trades on the OTCQB Venture Market (OTCQB: MDBIF).
- Game Changing Technology
- Multiple Applications and Use Cases
- Large, Underserved, Growing Market
- Positive Global Financial Benefit
- Superior Value Proposition
- Patent Protected Technology
- Regulatory Approvals on Track
Investors may find additional information on Medibio stock, including real-time quotes, announcements, filings, and history, at the Australian Stock Exchange (www.asx.com.au) and OTC Markets (www.otcmarkets.com). The Medibio share registry is maintained by Computershare, where shareholders can access information about shareholding.